← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Dynamis Therapeutics, Inc.
Jenkintown, PA
$1,723,980
Total funding
6
Grants
Funding over time
peak $257.6K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,723,980 · 6
By mechanism
R44$1,000,651 · 1
R43$723,329 · 5
Investigators at Dynamis Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
High Throughput Screen for Amadorase Inhibitors$845,835
R44 · FY2004 · DK
Discovery of FN3K Inhibitors to Treat Diabetic Complications$257,579
R43 · FY2010 · DK
High Throughput Screen for Amadorase Inhibitors$154,816
R44 · FY2005 · DK
New Inhibitors for Diabetic Retinopathy$133,750
R43 · FY2003 · EY
High Throughput Screen for Amadorase Inhibitors$132,000
R43 · FY2002 · DK
Cloning Amadorase: A Therapeutic Target for Nephropathy$100,000
R43 · FY2002 · DK
NEW INHIBITORS FOR DIABETIC NEPHROPATHY$100,000
R43 · FY2000 · DK